Theralase Technologies Inc. (TLTFF) filed a Form D to report a private offering of equity and related securities under Rule 506(b) of Regulation D. The issuer is a biotechnology company incorporated in Ontario, Canada, in the health care industry group.
The offering consists of units, with each unit including 1 common share and 1 common share purchase warrant. Each warrant is exercisable to acquire 1 common share at CAD$0.32 until May 20, 2031. The total offering amount is described as the unit price of 417,000 × CAD$0.24 plus the exercise price of the shares underlying the warrants of 417,000 × CAD$0.32, with no guarantee that the warrants will be exercised. As of this notice, $72,298 USD has been sold and $96,397 USD remains available, and no finders’ fees have been paid.